Medicare Coverage Determinations for Genetic Tests

As of May 2022 the Centers for Medicare and Medicaid has over 100 active LCDs and Articles pertaining to Genetics.  There are new potential Local Coverage Determinations and Articles that will be published in the future.

ID (A for Article L for LCD)TitleTypeMedicare Administrative Contractor
A57449Billing and Coding: BRCA1 and BRCA2 Genetic TestingArticleFirst Coast Service Options, Inc.
A56542Billing and Coding: BRCA1 and BRCA2 Genetic TestingArticleNovitas Solutions, Inc.
A58797Billing and Coding: Genetic Testing for Cardiovascular DiseaseArticleFirst Coast Service Options, Inc.
A58795Billing and Coding: Genetic Testing for Cardiovascular DiseaseArticleNovitas Solutions, Inc.
A57450Billing and Coding: Genetic Testing for Lynch SyndromeArticleFirst Coast Service Options, Inc.
A56971Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic TestingArticleCGS Administrators, LLC
A57354Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic TestingArticleNoridian Healthcare Solutions, LLC
A57355Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic TestingArticleNoridian Healthcare Solutions, LLC
A56854Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic TestingArticlePalmetto GBA
A57771Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic TestingArticleWisconsin Physicians Service Insurance Corporation
A54878Billing and Coding: MolDX: CDH1 Genetic TestingArticleCGS Administrators, LLC
A55970Billing and Coding: MolDX: CDH1 Genetic TestingArticleNoridian Healthcare Solutions, LLC
A55971Billing and Coding: MolDX: CDH1 Genetic TestingArticleNoridian Healthcare Solutions, LLC
A54835Billing and Coding: MolDX: CDH1 Genetic TestingArticlePalmetto GBA
A55622Billing and Coding: MolDX: CDH1 Genetic TestingArticleWisconsin Physicians Service Insurance Corporation
A54263Billing and Coding: MolDX: FANCC Genetic TestingArticleCGS Administrators, LLC
A55183Billing and Coding: MolDX: FANCC Genetic TestingArticleNoridian Healthcare Solutions, LLC
A55184Billing and Coding: MolDX: FANCC Genetic TestingArticleNoridian Healthcare Solutions, LLC
A53628Billing and Coding: MolDX: FANCC Genetic TestingArticlePalmetto GBA
A55160Billing and Coding: MolDX: FANCC Genetic TestingArticleWisconsin Physicians Service Insurance Corporation
A54265Billing and Coding: MolDX: GBA Genetic TestingArticleCGS Administrators, LLC
A55243Billing and Coding: MolDX: GBA Genetic TestingArticleNoridian Healthcare Solutions, LLC
A55244Billing and Coding: MolDX: GBA Genetic TestingArticleNoridian Healthcare Solutions, LLC
A53542Billing and Coding: MolDX: GBA Genetic TestingArticlePalmetto GBA
A55164Billing and Coding: MolDX: GBA Genetic TestingArticleWisconsin Physicians Service Insurance Corporation
A56999Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative DiseaseArticleCGS Administrators, LLC
A57421Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative DiseaseArticleNoridian Healthcare Solutions, LLC
A57422Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative DiseaseArticleNoridian Healthcare Solutions, LLC
A56959Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative DiseaseArticlePalmetto GBA
A57570Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative DiseaseArticleWisconsin Physicians Service Insurance Corporation
A56980Billing and Coding: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)ArticleCGS Administrators, LLC
A57423Billing and Coding: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)ArticleNoridian Healthcare Solutions, LLC
A57424Billing and Coding: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)ArticleNoridian Healthcare Solutions, LLC
A56899Billing and Coding: MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)ArticlePalmetto GBA
A57571Billing and Coding: MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)ArticleWisconsin Physicians Service Insurance Corporation
A56882Billing and Coding: MolDX: Genetic Testing for Lynch SyndromeArticleCGS Administrators, LLC
A54995Billing and Coding: MolDX: Genetic Testing for Lynch SyndromeArticleNoridian Healthcare Solutions, LLC
A54996Billing and Coding: MolDX: Genetic Testing for Lynch SyndromeArticleNoridian Healthcare Solutions, LLC
A54987Billing and Coding: MolDX: Genetic Testing for Lynch SyndromeArticlePalmetto GBA
A55135Billing and Coding: MolDX: Genetic Testing for Lynch SyndromeArticleWisconsin Physicians Service Insurance Corporation
A54270Billing and Coding: MolDX: IKBKAP Genetic TestingArticleCGS Administrators, LLC
A55612Billing and Coding: MolDX: IKBKAP Genetic TestingArticleNoridian Healthcare Solutions, LLC
A55613Billing and Coding: MolDX: IKBKAP Genetic TestingArticleNoridian Healthcare Solutions, LLC
A53596Billing and Coding: MolDX: IKBKAP Genetic TestingArticlePalmetto GBA
A55170Billing and Coding: MolDX: IKBKAP Genetic TestingArticleWisconsin Physicians Service Insurance Corporation
A55283Billing and Coding: MolDX: MCOLN1 Genetic TestingArticleNoridian Healthcare Solutions, LLC
A55284Billing and Coding: MolDX: MCOLN1 Genetic TestingArticleNoridian Healthcare Solutions, LLC
A53630Billing and Coding: MolDX: MCOLN1 Genetic TestingArticlePalmetto GBA
A55176Billing and Coding: MolDX: MCOLN1 Genetic TestingArticleWisconsin Physicians Service Insurance Corporation
A54277Billing and Coding: MolDX: MCOLN1 Genetic Testing GuidelinesArticleCGS Administrators, LLC
A53574Billing and Coding: MolDX: MECP2 GeneticArticlePalmetto GBA
A54278Billing and Coding: MolDX: MECP2 Genetic TestingArticleCGS Administrators, LLC
A55285Billing and Coding: MolDX: MECP2 Genetic TestingArticleNoridian Healthcare Solutions, LLC
A55286Billing and Coding: MolDX: MECP2 Genetic TestingArticleNoridian Healthcare Solutions, LLC
A55189Billing and Coding: MolDX: MECP2 Genetic TestingArticleWisconsin Physicians Service Insurance Corporation
A56998Billing and Coding: MolDX: NRAS Genetic TestingArticleCGS Administrators, LLC
A57486Billing and Coding: MolDX: NRAS Genetic TestingArticleNoridian Healthcare Solutions, LLC
A57487Billing and Coding: MolDX: NRAS Genetic TestingArticleNoridian Healthcare Solutions, LLC
A56962Billing and Coding: MolDX: NRAS Genetic TestingArticlePalmetto GBA
A57581Billing and Coding: MolDX: NRAS Genetic TestingArticleWisconsin Physicians Service Insurance Corporation
A54285Billing and Coding: MolDX: SMPD1 Genetic TestingArticleCGS Administrators, LLC
A55627Billing and Coding: MolDX: SMPD1 Genetic TestingArticleNoridian Healthcare Solutions, LLC
A55631Billing and Coding: MolDX: SMPD1 Genetic TestingArticleNoridian Healthcare Solutions, LLC
A53624Billing and Coding: MolDX: SMPD1 Genetic TestingArticlePalmetto GBA
A55208Billing and Coding: MolDX: SMPD1 Genetic TestingArticleWisconsin Physicians Service Insurance Corporation
A54283Billing and Coding: MolDX: SULT4A1 Genetic TestingArticleCGS Administrators, LLC
A55596Billing and Coding: MolDX: SULT4A1 Genetic TestingArticleNoridian Healthcare Solutions, LLC
A55601Billing and Coding: MolDX: SULT4A1 Genetic TestingArticleNoridian Healthcare Solutions, LLC
A53538Billing and Coding: MolDX: SULT4A1 Genetic TestingArticlePalmetto GBA
A55210Billing and Coding: MolDX: SULT4A1 Genetic TestingArticleWisconsin Physicians Service Insurance Corporation
A58918Billing and Coding: Molecular Pathology and Genetic TestingArticleFirst Coast Service Options, Inc.
A58917Billing and Coding: Molecular Pathology and Genetic TestingArticleNovitas Solutions, Inc.
L36499BRCA1 and BRCA2 Genetic TestingLCDFirst Coast Service Options, Inc.
L36715BRCA1 and BRCA2 Genetic TestingLCDNovitas Solutions, Inc.
DL39084
(Comments Ended 09/11/2021)
Genetic Testing for Cardiovascular DiseaseProposed LCDFirst Coast Service Options, Inc.
L39084Genetic Testing for Cardiovascular DiseaseLCDFirst Coast Service Options, Inc.
DL39082
(Comments Ended 09/11/2021)
Genetic Testing for Cardiovascular DiseaseProposed LCDNovitas Solutions, Inc.
L39082Genetic Testing for Cardiovascular DiseaseLCDNovitas Solutions, Inc.
L34912Genetic Testing for Lynch SyndromeLCDFirst Coast Service Options, Inc.
L36456MolDX: BRCA1 and BRCA2 Genetic TestingLCDCGS Administrators, LLC
L36161MolDX: BRCA1 and BRCA2 Genetic TestingLCDNoridian Healthcare Solutions, LLC
L36163MolDX: BRCA1 and BRCA2 Genetic TestingLCDNoridian Healthcare Solutions, LLC
L36082MolDX: BRCA1 and BRCA2 Genetic TestingLCDPalmetto GBA
L36813MolDX: BRCA1 and BRCA2 Genetic TestingLCDWisconsin Physicians Service Insurance Corporation
L36117MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative DiseaseLCDCGS Administrators, LLC
L36180MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative DiseaseLCDNoridian Healthcare Solutions, LLC
L36186MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative DiseaseLCDNoridian Healthcare Solutions, LLC
L36044MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative DiseaseLCDPalmetto GBA
L36815MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative DiseaseLCDWisconsin Physicians Service Insurance Corporation
L35984MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)LCDCGS Administrators, LLC
L36155MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)LCDNoridian Healthcare Solutions, LLC
L36159MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)LCDNoridian Healthcare Solutions, LLC
L36089MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)LCDPalmetto GBA
L36400MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)LCDWisconsin Physicians Service Insurance Corporation
L35349MolDX: Genetic Testing for Lynch SyndromeLCDCGS Administrators, LLC
L36370MolDX: Genetic Testing for Lynch SyndromeLCDNoridian Healthcare Solutions, LLC
L36374MolDX: Genetic Testing for Lynch SyndromeLCDNoridian Healthcare Solutions, LLC
L35024MolDX: Genetic Testing for Lynch SyndromeLCDPalmetto GBA
L36793MolDX: Genetic Testing for Lynch SyndromeLCDWisconsin Physicians Service Insurance Corporation
L35442MolDX: NRAS Genetic TestingLCDCGS Administrators, LLC
L36335MolDX: NRAS Genetic TestingLCDNoridian Healthcare Solutions, LLC
L36339MolDX: NRAS Genetic TestingLCDNoridian Healthcare Solutions, LLC
L35073MolDX: NRAS Genetic TestingLCDPalmetto GBA
L36797MolDX: NRAS Genetic TestingLCDWisconsin Physicians Service Insurance Corporation
A54612Response to Comments for MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative DiseaseArticleCGS Administrators, LLC
A55806Response to Comments: BRCA1 and BRCA2 Genetic TestingArticleFirst Coast Service Options, Inc.
A58956Response to Comments: Genetic Testing for Cardiovascular DiseaseArticleFirst Coast Service Options, Inc.
A58955Response to Comments: Genetic Testing for Cardiovascular DiseaseArticleNovitas Solutions, Inc.
A54921Response to Comments: Genetic Testing for CYP2C19, CYP2D6, CYP2C9, and VKORC1 (L36398).ArticleWisconsin Physicians Service Insurance Corporation
A54920Response to Comments: Genetic Testing for Hypercoagulability /Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) L36400 (A54920)ArticleWisconsin Physicians Service Insurance Corporation
A55385Response to Comments: MolDX-05: Breast Cancer Index℠ Genetic Assay (L36785)ArticleWisconsin Physicians Service Insurance Corporation
A54897Response to Comments: MolDX: BRCA1 and BRCA 2 Genetic TestingArticleNoridian Healthcare Solutions, LLC
A54898Response to Comments: MolDX: BRCA1 and BRCA 2 Genetic TestingArticleNoridian Healthcare Solutions, LLC
A54814Response to Comments: MolDX: BRCA1 and BRCA2 Genetic TestingArticleCGS Administrators, LLC
A55386Response to Comments: MolDX: BRCA1 and BRCA2 Genetic Testing (L36813)ArticleWisconsin Physicians Service Insurance Corporation
A56068Response to Comments: MolDX: Breast Cancer IndexSM Genetic AssayArticlePalmetto GBA
A54916Response to Comments: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative DiseaseArticleNoridian Healthcare Solutions, LLC
A54927Response to Comments: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative DiseaseArticleNoridian Healthcare Solutions, LLC
A55397Response to Comments: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease (L36815)ArticleWisconsin Physicians Service Insurance Corporation
A54893Response to Comments: MolDX: Genetic Testing for Hypercoagulability / ThrombophiliaArticleNoridian Healthcare Solutions, LLC
A54894Response to Comments: MolDX: Genetic Testing for Hypercoagulability / ThrombophiliaArticleNoridian Healthcare Solutions, LLC
A54964Response to Comments: MolDX: Genetic Testing for Lynch SyndromeArticleNoridian Healthcare Solutions, LLC
A54965Response to Comments: MolDX: Genetic Testing for Lynch SyndromeArticleNoridian Healthcare Solutions, LLC
A56361Response to Comments: MolDX: Genetic Testing for Lynch SyndromeArticleNoridian Healthcare Solutions, LLC
A56362Response to Comments: MolDX: Genetic Testing for Lynch SyndromeArticleNoridian Healthcare Solutions, LLC
A55399Response to Comments: MolDX: Genetic Testing for Lynch Syndrome (L36793)ArticleWisconsin Physicians Service Insurance Corporation
A54881Response to Comments: MolDX: HLA-B*15:02 Genetic TestingArticleCGS Administrators, LLC
A55380Response to Comments: MolDX: HLA-B*15:02 Genetic Testing (L36801)ArticleWisconsin Physicians Service Insurance Corporation
A55048Response to Comments: MolDX: NRAS Genetic TestingArticleNoridian Healthcare Solutions, LLC
A55049Response to Comments: MolDX: NRAS Genetic TestingArticleNoridian Healthcare Solutions, LLC
A55400Response to Comments: MolDX: NRAS Genetic Testing (L36797)ArticleWisconsin Physicians Service Insurance Corporation
L35395Autonomic Function TestsLCDNovitas Solutions, Inc.
A56526Billing and Coding: 3D Interpretation and Reporting of Imaging StudiesArticleNovitas Solutions, Inc.
A56485Billing and Coding: Assays for Vitamins and Metabolic FunctionArticlePalmetto GBA
A56589Billing and Coding: Barium Swallow Studies, ModifiedArticleNovitas Solutions, Inc.
A52986Billing and Coding: Biomarkers for OncologyArticleNovitas Solutions, Inc.
A57474Billing and Coding: Botulinum Toxin Type A & Type BArticleWisconsin Physicians Service Insurance Corporation
A57186Billing and Coding: Botulinum Toxin Types A and BArticleNoridian Healthcare Solutions, LLC
A57185Billing and Coding: Botulinum Toxin Types A and B PolicyArticleNoridian Healthcare Solutions, LLC
A56472Billing and Coding: Botulinum ToxinsArticleCGS Administrators, LLC
A52848Billing and Coding: Botulinum ToxinsArticleNational Government Services, Inc.
A56646Billing and Coding: ChemodenervationArticlePalmetto GBA
A52378Billing and Coding: Colorectal Cancer Screening – Medical Policy ArticleArticleNational Government Services, Inc.
A58774Billing and Coding: Cosmetic and Reconstructive SurgeryArticleWisconsin Physicians Service Insurance Corporation
A56612Billing and Coding: CT of the HeadArticlePalmetto GBA
A56464Billing and Coding: Flow CytometryArticleCGS Administrators, LLC
A57716Billing and Coding: Flow CytometryArticleFirst Coast Service Options, Inc.
A56676Billing and Coding: Flow CytometryArticleNovitas Solutions, Inc.
A56867Billing and Coding: Genomic Sequence Analysis Panels in the Treatment of Solid Organ NeoplasmsArticleNational Government Services, Inc.
A58192Billing and Coding: Guardant360®ArticleNoridian Healthcare Solutions, LLC
A58214Billing and Coding: Guardant360®ArticleNoridian Healthcare Solutions, LLC
A56326Billing and Coding: Implantable Automatic DefibrillatorsArticleNational Government Services, Inc.
A56340Billing and Coding: Implantable Automatic DefibrillatorsArticleNoridian Healthcare Solutions, LLC
A56342Billing and Coding: Implantable Automatic DefibrillatorsArticleNoridian Healthcare Solutions, LLC
A56343Billing and Coding: Implantable Automatic DefibrillatorsArticlePalmetto GBA
A56391Billing and Coding: Implantable Automatic DefibrillatorsArticleWisconsin Physicians Service Insurance Corporation
A57689Billing and Coding: Lab: Flow CytometryArticleNoridian Healthcare Solutions, LLC
A57690Billing and Coding: Lab: Flow CytometryArticleNoridian Healthcare Solutions, LLC
A55717Billing and Coding: Lab: Flow CytometryArticlePalmetto GBA
A54685Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) TestingArticleCGS Administrators, LLC
A54975Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) TestingArticleNoridian Healthcare Solutions, LLC
A54976Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) TestingArticleNoridian Healthcare Solutions, LLC
A53605Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) TestingArticlePalmetto GBA
A55235Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) TestingArticleWisconsin Physicians Service Insurance Corporation
A55088Billing and Coding: MolDX: Aspartoacyclase 2 Deficiency (ASPA) TestingArticleNoridian Healthcare Solutions, LLC
A55089Billing and Coding: MolDX: Aspartoacyclase 2 Deficiency (ASPA) TestingArticleNoridian Healthcare Solutions, LLC
A55142Billing and Coding: MolDX: Aspartoacyclase 2 Deficiency (ASPA) TestingArticleWisconsin Physicians Service Insurance Corporation
A54253Billing and Coding: MolDX: Aspartoacyclase 2 Deficiency(ASPA) TestingArticleCGS Administrators, LLC
A53602Billing and Coding: MolDX: Aspartoacyclase 2 Deficiency(ASPA) TestingArticlePalmetto GBA
A54254Billing and Coding: MolDX: ATP7B Gene TestsArticleCGS Administrators, LLC
A55097Billing and Coding: MolDX: ATP7B Gene TestsArticleNoridian Healthcare Solutions, LLC
A55098Billing and Coding: MolDX: ATP7B Gene TestsArticleNoridian Healthcare Solutions, LLC
A53550Billing and Coding: MolDX: ATP7B Gene TestsArticlePalmetto GBA
A55143Billing and Coding: MolDX: ATP7B Gene TestsArticleWisconsin Physicians Service Insurance Corporation
A54255Billing and Coding: MolDX: BCKDHB Gene TestArticleCGS Administrators, LLC
A55099Billing and Coding: MolDX: BCKDHB Gene TestArticleNoridian Healthcare Solutions, LLC
A55100Billing and Coding: MolDX: BCKDHB Gene TestArticleNoridian Healthcare Solutions, LLC
A53600Billing and Coding: MolDX: BCKDHB Gene TestArticlePalmetto GBA
A55145Billing and Coding: MolDX: BCKDHB Gene TestArticleWisconsin Physicians Service Insurance Corporation
A54256Billing and Coding: MolDX: BLM Gene AnalysisArticleCGS Administrators, LLC
A55113Billing and Coding: MolDX: BLM Gene AnalysisArticleNoridian Healthcare Solutions, LLC
A55114Billing and Coding: MolDX: BLM Gene AnalysisArticleNoridian Healthcare Solutions, LLC
A53540Billing and Coding: MolDX: BLM Gene AnalysisArticlePalmetto GBA
A55148Billing and Coding: MolDX: BLM Gene AnalysisArticleWisconsin Physicians Service Insurance Corporation
A54262Billing and Coding: MolDX: ENG and ACVRL1 Gene TestsArticleCGS Administrators, LLC
A55181Billing and Coding: MolDX: ENG and ACVRL1 Gene TestsArticleNoridian Healthcare Solutions, LLC
A55182Billing and Coding: MolDX: ENG and ACVRL1 Gene TestsArticleNoridian Healthcare Solutions, LLC
A53536Billing and Coding: MolDX: ENG and ACVRL1 Gene TestsArticlePalmetto GBA
A55159Billing and Coding: MolDX: ENG and ACVRL1 Gene TestsArticleWisconsin Physicians Service Insurance Corporation
A54191Billing and Coding: MolDX: FDA-Approved BRAF TestsArticleCGS Administrators, LLC
A54418Billing and Coding: MolDX: FDA-Approved BRAF TestsArticleNoridian Healthcare Solutions, LLC
A54420Billing and Coding: MolDX: FDA-Approved BRAF TestsArticleNoridian Healthcare Solutions, LLC
A54018Billing and Coding: MolDX: FDA-Approved BRAF TestsArticlePalmetto GBA
A55161Billing and Coding: MolDX: FDA-Approved BRAF TestsArticleWisconsin Physicians Service Insurance Corporation
A54192Billing and Coding: MolDX: FDA-Approved EGFR TestsArticleCGS Administrators, LLC
A54422Billing and Coding: MolDX: FDA-Approved EGFR TestsArticleNoridian Healthcare Solutions, LLC
A54424Billing and Coding: MolDX: FDA-Approved EGFR TestsArticleNoridian Healthcare Solutions, LLC
A54021Billing and Coding: MolDX: FDA-Approved EGFR TestsArticlePalmetto GBA
A55193Billing and Coding: MolDX: FDA-Approved EGFR TestsArticleWisconsin Physicians Service Insurance Corporation
A54688Billing and Coding: MolDX: FDA-Approved KRAS TestsArticleCGS Administrators, LLC
A54498Billing and Coding: MolDX: FDA-Approved KRAS TestsArticleNoridian Healthcare Solutions, LLC
A54500Billing and Coding: MolDX: FDA-Approved KRAS TestsArticleNoridian Healthcare Solutions, LLC
A54472Billing and Coding: MolDX: FDA-Approved KRAS TestsArticlePalmetto GBA
A55162Billing and Coding: MolDX: FDA-Approved KRAS TestsArticleWisconsin Physicians Service Insurance Corporation
A54267Billing and Coding: MolDX: HBB Gene TestsArticleCGS Administrators, LLC
A55253Billing and Coding: MolDX: HBB Gene TestsArticleNoridian Healthcare Solutions, LLC
A55254Billing and Coding: MolDX: HBB Gene TestsArticleNoridian Healthcare Solutions, LLC
A53493Billing and Coding: MolDX: HBB Gene TestsArticlePalmetto GBA
A55166Billing and Coding: MolDX: HBB Gene TestsArticleWisconsin Physicians Service Insurance Corporation
A54268Billing and Coding: MolDX: HEXA Gene AnalysisArticleCGS Administrators, LLC
A55255Billing and Coding: MolDX: HEXA Gene AnalysisArticleNoridian Healthcare Solutions, LLC
A55256Billing and Coding: MolDX: HEXA Gene AnalysisArticleNoridian Healthcare Solutions, LLC
A53598Billing and Coding: MolDX: HEXA Gene AnalysisArticlePalmetto GBA
A55168Billing and Coding: MolDX: HEXA Gene AnalysisArticleWisconsin Physicians Service Insurance Corporation
A55277Billing and Coding: MolDX: L1CAM Gene SequencingArticleNoridian Healthcare Solutions, LLC
A55278Billing and Coding: MolDX: L1CAM Gene SequencingArticleNoridian Healthcare Solutions, LLC
A53659Billing and Coding: MolDX: L1CAM Gene SequencingArticlePalmetto GBA
A55192Billing and Coding: MolDX: L1CAM Gene SequencingArticleWisconsin Physicians Service Insurance Corporation
A54274Billing and Coding: MolDX: L1CAM Gene Sequencing GuidelinesArticleCGS Administrators, LLC
A58998Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic CancersArticleCGS Administrators, LLC
A58996Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic CancersArticleNoridian Healthcare Solutions, LLC
A58997Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic CancersArticleNoridian Healthcare Solutions, LLC
A58988Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic CancersArticlePalmetto GBA
A59004Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic CancersArticleWisconsin Physicians Service Insurance Corporation
A58434Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor CancersArticleCGS Administrators, LLC
A58454Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor CancersArticleNoridian Healthcare Solutions, LLC
A58456Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor CancersArticleNoridian Healthcare Solutions, LLC
A58376Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor CancersArticlePalmetto GBA
A58468Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor CancersArticleWisconsin Physicians Service Insurance Corporation
A55290Billing and Coding: MolDX: Mitochondrial Nuclear Gene TestsArticleNoridian Healthcare Solutions, LLC
A55291Billing and Coding: MolDX: Mitochondrial Nuclear Gene TestsArticleNoridian Healthcare Solutions, LLC
A53669Billing and Coding: MolDX: Mitochondrial Nuclear Gene TestsArticlePalmetto GBA
A55190Billing and Coding: MolDX: Mitochondrial Nuclear Gene TestsArticleWisconsin Physicians Service Insurance Corporation
A54288Billing and Coding: MolDX: Mitochondrial Nuclear Gene Tests GuidelinesArticleCGS Administrators, LLC
A56973Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT)ArticleCGS Administrators, LLC
A57526Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT)ArticleNoridian Healthcare Solutions, LLC
A57527Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT)ArticleNoridian Healthcare Solutions, LLC
A56853Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT)ArticlePalmetto GBA
A57772Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT)ArticleWisconsin Physicians Service Insurance Corporation
A54689Billing and Coding: MolDX: Myriad’s BRACAnalysis CDx®ArticleCGS Administrators, LLC
A55294Billing and Coding: MolDX: Myriad’s BRACAnalysis CDx®ArticleNoridian Healthcare Solutions, LLC
A55295Billing and Coding: MolDX: Myriad’s BRACAnalysis CDx®ArticleNoridian Healthcare Solutions, LLC
A54338Billing and Coding: MolDX: Myriad’s BRACAnalysis CDx®ArticlePalmetto GBA
A55224Billing and Coding: MolDX: Myriad’s BRACAnalysis CDx®ArticleWisconsin Physicians Service Insurance Corporation
A54291Billing and Coding: MolDX: NSD1 Gene TestsArticleCGS Administrators, LLC
A55609Billing and Coding: MolDX: NSD1 Gene TestsArticleNoridian Healthcare Solutions, LLC
A55615Billing and Coding: MolDX: NSD1 Gene TestsArticleNoridian Healthcare Solutions, LLC
A53585Billing and Coding: MolDX: NSD1 Gene TestsArticlePalmetto GBA
A55198Billing and Coding: MolDX: NSD1 Gene TestsArticleWisconsin Physicians Service Insurance Corporation
A55625Billing and Coding: MolDX: PAX6 Gene SequencingArticleNoridian Healthcare Solutions, LLC
A55632Billing and Coding: MolDX: PAX6 Gene SequencingArticleNoridian Healthcare Solutions, LLC
A53664Billing and Coding: MolDX: PAX6 Gene SequencingArticlePalmetto GBA
A55199Billing and Coding: MolDX: PAX6 Gene SequencingArticleWisconsin Physicians Service Insurance Corporation
A54293Billing and Coding: MolDX: PAX6 Gene Sequencing GuidelinesArticleCGS Administrators, LLC
A57141Billing and Coding: MolDX: Repeat Germline TestingArticleCGS Administrators, LLC
A57331Billing and Coding: MolDX: Repeat Germline TestingArticleNoridian Healthcare Solutions, LLC
A57332Billing and Coding: MolDX: Repeat Germline TestingArticleNoridian Healthcare Solutions, LLC
A58017Billing and Coding: MolDX: Repeat Germline TestingArticlePalmetto GBA
A57100Billing and Coding: MolDX: Repeat Germline TestingArticleWisconsin Physicians Service Insurance Corporation
A54299Billing and Coding: MolDX: RPS19 Gene TestsArticleCGS Administrators, LLC
A55610Billing and Coding: MolDX: RPS19 Gene TestsArticleNoridian Healthcare Solutions, LLC
A55614Billing and Coding: MolDX: RPS19 Gene TestsArticleNoridian Healthcare Solutions, LLC
A53587Billing and Coding: MolDX: RPS19 Gene TestsArticlePalmetto GBA
A55205Billing and Coding: MolDX: RPS19 Gene TestsArticleWisconsin Physicians Service Insurance Corporation
A57910Billing and Coding: MolDX: Testing of Multiple GenesArticleCGS Administrators, LLC
A58120Billing and Coding: MolDX: Testing of Multiple GenesArticleNoridian Healthcare Solutions, LLC
A58121Billing and Coding: MolDX: Testing of Multiple GenesArticleNoridian Healthcare Solutions, LLC
A57503Billing and Coding: MolDX: Testing of Multiple GenesArticlePalmetto GBA
A57880Billing and Coding: MolDX: Testing of Multiple GenesArticleWisconsin Physicians Service Insurance Corporation
A54200Billing and Coding: MolDX: therascreen® KRAS PCR Kit GuidelinesArticleCGS Administrators, LLC
A57451Billing and Coding: Molecular Pathology ProceduresArticleFirst Coast Service Options, Inc.
A56199Billing and Coding: Molecular Pathology ProceduresArticleNational Government Services, Inc.
A57361Billing and Coding: Monitored Anesthesia CareArticleNovitas Solutions, Inc.
A57204Billing and Coding: MRI and CT Scans of the Head and NeckArticleNoridian Healthcare Solutions, LLC
A57215Billing and Coding: MRI and CT Scans of the Head and NeckArticleNoridian Healthcare Solutions, LLC
A57307Billing and Coding: Nerve Conduction Studies and ElectromyographyArticleCGS Administrators, LLC
A57123Billing and Coding: Nerve Conduction Studies and ElectromyographyArticleFirst Coast Service Options, Inc.
A57668Billing and Coding: Nerve Conduction Studies and ElectromyographyArticleNational Government Services, Inc.
A54969Billing and Coding: Nerve Conduction Studies and ElectromyographyArticleNoridian Healthcare Solutions, LLC
A54992Billing and Coding: Nerve Conduction Studies and ElectromyographyArticleNoridian Healthcare Solutions, LLC
A54095Billing and Coding: Nerve Conduction Studies and ElectromyographyArticleNovitas Solutions, Inc.
A56619Billing and Coding: Nerve Conduction Studies and ElectromyographyArticlePalmetto GBA
A57478Billing and Coding: Nerve Conduction Studies and ElectromyographyArticleWisconsin Physicians Service Insurance Corporation
A56773Billing and Coding: Neurophysiology Evoked Potentials (NEPs)ArticleNovitas Solutions, Inc.
A58812Billing and Coding: Pharmacogenomics TestingArticleFirst Coast Service Options, Inc.
A58801Billing and Coding: Pharmacogenomics TestingArticleNovitas Solutions, Inc.
A57130Billing and Coding: Psychiatric CodesArticleNovitas Solutions, Inc.
A57052Billing and Coding: Psychiatric Inpatient HospitalizationArticleCGS Administrators, LLC
A56865Billing and Coding: Psychiatric Inpatient HospitalizationArticleNational Government Services, Inc.
A57053Billing and Coding: Psychiatric Partial Hospitalization ProgramsArticleCGS Administrators, LLC
A57780Billing and Coding: Psychological and Neuropsychological TestsArticleFirst Coast Service Options, Inc.
A54111Billing and Coding: Speech Language Pathology (SLP) Services: Communication DisordersArticleNovitas Solutions, Inc.
A56802Billing and Coding: UrodynamicsArticleCGS Administrators, LLC
A57455Billing and Coding: UrodynamicsArticleNational Government Services, Inc.
A57434Billing and Coding: Vestibular and Audiologic Function StudiesArticleNovitas Solutions, Inc.
L37851Biomarker Testing for Neuroendocrine Tumors/NeoplasmsLCDNational Government Services, Inc.
L35396Biomarkers for OncologyLCDNovitas Solutions, Inc.
L35062Biomarkers OverviewLCDNovitas Solutions, Inc.
L33270Bisphosphonates (Intravenous [IV]) and Monoclonal Antibodies in the Treatment of Osteoporosis and Their Other IndicationsLCDFirst Coast Service Options, Inc.
L36356Bone Mineral Density StudiesLCDFirst Coast Service Options, Inc.
L34856C-Reactive Protein High Sensitivity Testing (hsCRP)LCDNovitas Solutions, Inc.
L37126Coenzyme Q10 (CoQ10)LCDCGS Administrators, LLC
L34213Diagnostic and Therapeutic ColonoscopyLCDNoridian Healthcare Solutions, LLC
L36868Diagnostic and Therapeutic ColonoscopyLCDNoridian Healthcare Solutions, LLC
L37606Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid DiseasesLCDNational Government Services, Inc.
DL37810
(Comments Ended 11/13/2021)
Genomic Sequence Analysis Panels in the Treatment of Solid Organ NeoplasmsProposed LCDNational Government Services, Inc.
L37810
(Notice Ended 03/31/2022)
Genomic Sequence Analysis Panels in the Treatment of Solid Organ NeoplasmsLCDNational Government Services, Inc.
A52434Health and Behavior Assessment/Intervention – Medical Policy ArticleArticleNational Government Services, Inc.
L33684Hemophilia Clotting FactorsLCDFirst Coast Service Options, Inc.
L35427Hyaluronan Acid Therapies for Osteoarthritis of the KneeLCDNovitas Solutions, Inc.
L34007Intravenous Immune GlobulinLCDFirst Coast Service Options, Inc.
L34580Intravenous Immunoglobulin (IVIG)LCDPalmetto GBA
L37066Lab: Coenzyme Q10 (CoQ10)LCDNoridian Healthcare Solutions, LLC
L37068Lab: Coenzyme Q10 (CoQ10)LCDNoridian Healthcare Solutions, LLC
L37022Lab: Coenzyme Q10 (CoQ10)LCDPalmetto GBA
L34215Lab: Flow CytometryLCDNoridian Healthcare Solutions, LLC
L36094Lab: Flow CytometryLCDNoridian Healthcare Solutions, LLC
L34513Lab: Flow CytometryLCDPalmetto GBA
L34864Loss-of-Heterozygosity Based Topographic Genotyping with PathfinderTG ®LCDNovitas Solutions, Inc.
L37608MDS FISHLCDCGS Administrators, LLC
L37620MDS FISHLCDNoridian Healthcare Solutions, LLC
L37622MDS FISHLCDNoridian Healthcare Solutions, LLC
L37602MDS FISHLCDPalmetto GBA
L37772MDS FISHLCDWisconsin Physicians Service Insurance Corporation
L35702Mohs Micrographic SurgeryLCDNoridian Healthcare Solutions, LLC
L35704Mohs Micrographic SurgeryLCDNoridian Healthcare Solutions, LLC
L35494Mohs Micrographic SurgeryLCDWisconsin Physicians Service Insurance Corporation
L33689Mohs Micrographic Surgery (MMS)LCDFirst Coast Service Options, Inc.
L34961Mohs Micrographic Surgery (MMS)LCDNovitas Solutions, Inc.
L38355MolDX: AlloSure® or Equivalent Cell-Free DNA Testing for Kidney and Heart AllograftsLCDNoridian Healthcare Solutions, LLC
L38380MolDX: AlloSure® or Equivalent Cell-Free DNA Testing for Kidney and Heart AllograftsLCDNoridian Healthcare Solutions, LLC
L36910MolDX: APC and MUTYH Gene TestingLCDCGS Administrators, LLC
L36882MolDX: APC and MUTYH Gene TestingLCDNoridian Healthcare Solutions, LLC
L36884MolDX: APC and MUTYH Gene TestingLCDNoridian Healthcare Solutions, LLC
L36827MolDX: APC and MUTYH Gene TestingLCDPalmetto GBA
L37224MolDX: APC and MUTYH Gene TestingLCDWisconsin Physicians Service Insurance Corporation
L36139MolDX: Biomarkers in Cardiovascular Risk AssessmentLCDCGS Administrators, LLC
L36358MolDX: Biomarkers in Cardiovascular Risk AssessmentLCDNoridian Healthcare Solutions, LLC
L36362MolDX: Biomarkers in Cardiovascular Risk AssessmentLCDNoridian Healthcare Solutions, LLC
L36129MolDX: Biomarkers in Cardiovascular Risk AssessmentLCDPalmetto GBA
L36523MolDX: Biomarkers in Cardiovascular Risk AssessmentLCDWisconsin Physicians Service Insurance Corporation
DL38997
(Comments Ended 08/07/2021)
MolDX: Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate CancerProposed LCDCGS Administrators, LLC
DL39005
(Comments Ended 07/03/2021)
MolDX: Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate CancerProposed LCDNoridian Healthcare Solutions, LLC
DL39007
(Comments Ended 07/03/2021)
MolDX: Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate CancerProposed LCDNoridian Healthcare Solutions, LLC
DL38985
(Comments Ended 07/03/2021)
MolDX: Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate CancerProposed LCDPalmetto GBA
DL39042
(Comments Ended 07/03/2021)
MolDX: Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate CancerProposed LCDWisconsin Physicians Service Insurance Corporation
L38249MolDX: Blood Product Molecular Antigen TypingLCDCGS Administrators, LLC
L38331MolDX: Blood Product Molecular Antigen TypingLCDNoridian Healthcare Solutions, LLC
L38333MolDX: Blood Product Molecular Antigen TypingLCDNoridian Healthcare Solutions, LLC
L38240MolDX: Blood Product Molecular Antigen TypingLCDPalmetto GBA
L38441MolDX: Blood Product Molecular Antigen TypingLCDWisconsin Physicians Service Insurance Corporation
L37832MolDX: Breast Cancer Index® (BCI) Gene Expression TestLCDCGS Administrators, LLC
L37822MolDX: Breast Cancer Index® (BCI) Gene Expression TestLCDNoridian Healthcare Solutions, LLC
L37824MolDX: Breast Cancer Index® (BCI) Gene Expression TestLCDNoridian Healthcare Solutions, LLC
L37794MolDX: Breast Cancer Index® (BCI) Gene Expression TestLCDPalmetto GBA
L37913MolDX: Breast Cancer Index® (BCI) Gene Expression TestLCDWisconsin Physicians Service Insurance Corporation
L37210MolDX: Decision Dx-UM (Uveal Melanoma)LCDWisconsin Physicians Service Insurance Corporation
L37130MolDX: DecisionDx-UM (Uveal Melanoma)LCDCGS Administrators, LLC
L37070MolDX: DecisionDx-UM (Uveal Melanoma)LCDNoridian Healthcare Solutions, LLC
L37072MolDX: DecisionDx-UM (Uveal Melanoma)LCDNoridian Healthcare Solutions, LLC
L37033MolDX: DecisionDx-UM (Uveal Melanoma)LCDPalmetto GBA
L37356MolDX: EndoPredict Breast Cancer Gene Expression TestLCDCGS Administrators, LLC
L37264MolDX: EndoPredict Breast Cancer Gene Expression TestLCDPalmetto GBA
DL37295
(Comments Ended 07/12/2020)
MolDX: EndoPredict® Breast Cancer Gene Expression TestProposed LCDNoridian Healthcare Solutions, LLC
DL37311
(Comments Ended 07/12/2020)
MolDX: EndoPredict® Breast Cancer Gene Expression TestProposed LCDNoridian Healthcare Solutions, LLC
L37295MolDX: EndoPredict® Breast Cancer Gene Expression TestLCDNoridian Healthcare Solutions, LLC
L37311MolDX: EndoPredict® Breast Cancer Gene Expression TestLCDNoridian Healthcare Solutions, LLC
L37663MolDX: EndoPredict® Breast Cancer Gene Expression TestLCDWisconsin Physicians Service Insurance Corporation
L37905MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic TestLCDCGS Administrators, LLC
L37887MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic TestLCDNoridian Healthcare Solutions, LLC
L37891MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic TestLCDNoridian Healthcare Solutions, LLC
L37857MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic TestLCDPalmetto GBA
L37919MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic TestLCDWisconsin Physicians Service Insurance Corporation
L36485MolDX: HLA-DQB1*06:02 Testing for NarcolepsyLCDCGS Administrators, LLC
L36544MolDX: HLA-DQB1*06:02 Testing for NarcolepsyLCDNoridian Healthcare Solutions, LLC
L36551MolDX: HLA-DQB1*06:02 Testing for NarcolepsyLCDNoridian Healthcare Solutions, LLC
L36464MolDX: HLA-DQB1*06:02 Testing for NarcolepsyLCDPalmetto GBA
L37003MolDX: HLA-DQB1*06:02 Testing for NarcolepsyLCDWisconsin Physicians Service Insurance Corporation
L37903MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung CancerLCDCGS Administrators, LLC
L37897MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung CancerLCDNoridian Healthcare Solutions, LLC
L37870MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung CancerLCDPalmetto GBA
L37921MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung CancerLCDWisconsin Physicians Service Insurance Corporation
L37899MolDX: Inivata™, InvisionFirst®, Liquid Biopsy for Patients with Lung CancerLCDNoridian Healthcare Solutions, LLC
DL38629
(Comments Ended 07/12/2020)
MolDX: Liquid Biopsies for Solid Organ TransplantationProposed LCDNoridian Healthcare Solutions, LLC
DL38671
(Comments Ended 07/12/2020)
MolDX: Liquid Biopsies for Solid Organ TransplantationProposed LCDNoridian Healthcare Solutions, LLC
DL38016
(Comments Ended 08/07/2021)
MolDX: Melanoma Risk Stratification Molecular TestingProposed LCDCGS Administrators, LLC
L38016MolDX: Melanoma Risk Stratification Molecular TestingLCDCGS Administrators, LLC
DL37748
(Comments Ended 07/03/2021)
MolDX: Melanoma Risk Stratification Molecular TestingProposed LCDNoridian Healthcare Solutions, LLC
DL37750
(Comments Ended 07/03/2021)
MolDX: Melanoma Risk Stratification Molecular TestingProposed LCDNoridian Healthcare Solutions, LLC
L37748MolDX: Melanoma Risk Stratification Molecular TestingLCDNoridian Healthcare Solutions, LLC
L37750MolDX: Melanoma Risk Stratification Molecular TestingLCDNoridian Healthcare Solutions, LLC
DL37725
(Comments Ended 07/03/2021)
MolDX: Melanoma Risk Stratification Molecular TestingProposed LCDPalmetto GBA
L37725MolDX: Melanoma Risk Stratification Molecular TestingLCDPalmetto GBA
DL38018
(Comments Ended 07/03/2021)
MolDX: Melanoma Risk Stratification Molecular TestingProposed LCDWisconsin Physicians Service Insurance Corporation
L38018MolDX: Melanoma Risk Stratification Molecular TestingLCDWisconsin Physicians Service Insurance Corporation
L36113MolDX: MGMT Promoter Methylation AnalysisLCDCGS Administrators, LLC
L36188MolDX: MGMT Promoter Methylation AnalysisLCDNoridian Healthcare Solutions, LLC
L36192MolDX: MGMT Promoter Methylation AnalysisLCDNoridian Healthcare Solutions, LLC
L35974MolDX: MGMT Promoter Methylation AnalysisLCDPalmetto GBA
L37001MolDX: MGMT Promoter Methylation AnalysisLCDWisconsin Physicians Service Insurance Corporation
DL38822
(Comments Ended 11/15/2020)
MolDX: Minimal Residual Disease Testing for CancerProposed LCDCGS Administrators, LLC
L38822MolDX: Minimal Residual Disease Testing for CancerLCDCGS Administrators, LLC
DL38814
(Comments Ended 11/22/2020)
MolDX: Minimal Residual Disease Testing for CancerProposed LCDNoridian Healthcare Solutions, LLC
DL38816
(Comments Ended 11/22/2020)
MolDX: Minimal Residual Disease Testing for CancerProposed LCDNoridian Healthcare Solutions, LLC
L38814MolDX: Minimal Residual Disease Testing for CancerLCDNoridian Healthcare Solutions, LLC
L38816MolDX: Minimal Residual Disease Testing for CancerLCDNoridian Healthcare Solutions, LLC
DL38779
(Comments Ended 11/07/2020)
MolDX: Minimal Residual Disease Testing for CancerProposed LCDPalmetto GBA
L38779MolDX: Minimal Residual Disease Testing for CancerLCDPalmetto GBA
DL38835
(Comments Ended 11/14/2020)
MolDX: Minimal Residual Disease Testing for CancerProposed LCDWisconsin Physicians Service Insurance Corporation
L38835MolDX: Minimal Residual Disease Testing for CancerLCDWisconsin Physicians Service Insurance Corporation
DL39262
(Comments End 06/11/2022)
MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and NeoplasiaProposed LCDNoridian Healthcare Solutions, LLC
DL39264
(Comments End 06/11/2022)
MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and NeoplasiaProposed LCDNoridian Healthcare Solutions, LLC
DL39256
(Comments End 05/14/2022)
MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and NeoplasiaProposed LCDPalmetto GBA
L38582MolDX: Molecular Testing for Solid Organ Allograft RejectionLCDCGS Administrators, LLC
L38629MolDX: Molecular Testing for Solid Organ Allograft RejectionLCDNoridian Healthcare Solutions, LLC
L38671MolDX: Molecular Testing for Solid Organ Allograft RejectionLCDNoridian Healthcare Solutions, LLC
L38568MolDX: Molecular Testing for Solid Organ Allograft RejectionLCDPalmetto GBA
L38680MolDx: Molecular Testing for Solid Organ Allograft RejectionLCDWisconsin Physicians Service Insurance Corporation
L37907MolDX: myPath Melanoma AssayLCDCGS Administrators, LLC
L37879MolDX: myPath® Melanoma AssayLCDNoridian Healthcare Solutions, LLC
L37881MolDX: myPath® Melanoma AssayLCDNoridian Healthcare Solutions, LLC
L37859MolDX: myPath® Melanoma AssayLCDPalmetto GBA
L37923MolDX: myPath® Melanoma AssayLCDWisconsin Physicians Service Insurance Corporation
L38067MolDX: Next-Generation Sequencing for Solid TumorsLCDCGS Administrators, LLC
L38119MolDX: Next-Generation Sequencing for Solid TumorsLCDNoridian Healthcare Solutions, LLC
L38121MolDX: Next-Generation Sequencing for Solid TumorsLCDNoridian Healthcare Solutions, LLC
L38045MolDX: Next-Generation Sequencing for Solid TumorsLCDPalmetto GBA
L38158MolDX: Next-Generation Sequencing for Solid TumorsLCDWisconsin Physicians Service Insurance Corporation
DL39017
(Comments Ended 08/07/2021)
MolDX: Next-Generation Sequencing Lab-Developed Tests for Inherited Cancer SyndromesProposed LCDCGS Administrators, LLC
DL38972
(Comments Ended 07/03/2021)
MolDX: Next-Generation Sequencing Lab-Developed Tests for Inherited Cancer SyndromesProposed LCDNoridian Healthcare Solutions, LLC
DL38974
(Comments Ended 07/03/2021)
MolDX: Next-Generation Sequencing Lab-Developed Tests for Inherited Cancer SyndromesProposed LCDNoridian Healthcare Solutions, LLC
DL38966
(Comments Ended 07/31/2021)
MolDX: Next-Generation Sequencing Lab-Developed Tests for Inherited Cancer SyndromesProposed LCDPalmetto GBA
DL39040
(Comments Ended 07/03/2021)
MolDX: Next-Generation Sequencing Lab-Developed Tests for Inherited Cancer SyndromesProposed LCDWisconsin Physicians Service Insurance Corporation
L38070MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid MalignanciesLCDCGS Administrators, LLC
L38123MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid MalignanciesLCDNoridian Healthcare Solutions, LLC
L38125MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid MalignanciesLCDNoridian Healthcare Solutions, LLC
L38047MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid MalignanciesLCDPalmetto GBA
L38176MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid MalignanciesLCDWisconsin Physicians Service Insurance Corporation
L38394MolDX: Pharmacogenomics TestingLCDCGS Administrators, LLC
L38335MolDX: Pharmacogenomics TestingLCDNoridian Healthcare Solutions, LLC
L38337MolDX: Pharmacogenomics TestingLCDNoridian Healthcare Solutions, LLC
L38294MolDX: Pharmacogenomics TestingLCDPalmetto GBA
L38435MolDX: Pharmacogenomics TestingLCDWisconsin Physicians Service Insurance Corporation
L38584MolDX: Phenotypic Biomarker Detection from Circulating Tumor CellsLCDCGS Administrators, LLC
L38643MolDX: Phenotypic Biomarker Detection from Circulating Tumor CellsLCDNoridian Healthcare Solutions, LLC
L38645MolDX: Phenotypic Biomarker Detection from Circulating Tumor CellsLCDNoridian Healthcare Solutions, LLC
L38678MolDX: Phenotypic Biomarker Detection from Circulating Tumor CellsLCDWisconsin Physicians Service Insurance Corporation
DL38643
(Comments Ended 07/12/2020)
MolDX: Phenotypic Biomarker Detection in Circulating Tumor CellsProposed LCDNoridian Healthcare Solutions, LLC
DL38645
(Comments Ended 07/12/2020)
MolDX: Phenotypic Biomarker Detection in Circulating Tumor CellsProposed LCDNoridian Healthcare Solutions, LLC
L38566MolDX: Phenotypic Biomarker Detection in Circulating Tumor CellsLCDPalmetto GBA
DL38678
(Comments Ended 07/11/2020)
MolDX: Phenotypic Biomarker Detection in Circulating Tumor CellsProposed LCDWisconsin Physicians Service Insurance Corporation
L38111MolDX: Pigmented Lesion AssayLCDCGS Administrators, LLC
L38151MolDX: Pigmented Lesion AssayLCDNoridian Healthcare Solutions, LLC
L38153MolDX: Pigmented Lesion AssayLCDNoridian Healthcare Solutions, LLC
L38051MolDX: Pigmented Lesion AssayLCDPalmetto GBA
L38178MolDX: Pigmented Lesion AssayLCDWisconsin Physicians Service Insurance Corporation
L38065MolDX: Plasma-Based Genomic Profiling in Solid TumorsLCDCGS Administrators, LLC
DL39230
(Comments Ended 03/05/2022)
MolDX: Plasma-Based Genomic Profiling in Solid TumorsProposed LCDNoridian Healthcare Solutions, LLC
DL39232
(Comments Ended 03/05/2022)
MolDX: Plasma-Based Genomic Profiling in Solid TumorsProposed LCDNoridian Healthcare Solutions, LLC
L38043MolDX: Plasma-Based Genomic Profiling in Solid TumorsLCDPalmetto GBA
L38168MolDX: Plasma-Based Genomic Profiling in Solid TumorsLCDWisconsin Physicians Service Insurance Corporation
L38284MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung CancerLCDCGS Administrators, LLC
L38327MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung CancerLCDNoridian Healthcare Solutions, LLC
L38329MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung CancerLCDNoridian Healthcare Solutions, LLC
L38238MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung CancerLCDPalmetto GBA
L38443MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung CancerLCDWisconsin Physicians Service Insurance Corporation
L38586MolDX: Prognostic and Predictive Molecular Classifiers for Bladder CancerLCDCGS Administrators, LLC
L38647MolDX: Prognostic and Predictive Molecular Classifiers for Bladder CancerLCDNoridian Healthcare Solutions, LLC
L38649MolDX: Prognostic and Predictive Molecular Classifiers for Bladder CancerLCDNoridian Healthcare Solutions, LLC
L38576MolDX: Prognostic and Predictive Molecular Classifiers for Bladder CancerLCDPalmetto GBA
DL38684
(Comments Ended 07/11/2020)
MolDX: Prognostic and Predictive Molecular Classifiers for Bladder CancerProposed LCDWisconsin Physicians Service Insurance Corporation
L38684MolDX: Prognostic and Predictive Molecular Classifiers for Bladder CancerLCDWisconsin Physicians Service Insurance Corporation
L37352MolDX: Prometheus IBD sgi Diagnostic® PolicyLCDCGS Administrators, LLC
L37299MolDX: Prometheus IBD sgi Diagnostic® PolicyLCDNoridian Healthcare Solutions, LLC
L37313MolDX: Prometheus IBD sgi Diagnostic® PolicyLCDNoridian Healthcare Solutions, LLC
L37260MolDX: Prometheus IBD sgi Diagnostic® PolicyLCDPalmetto GBA
L37539MolDX: Prometheus IBD sgi Diagnostic® PolicyLCDWisconsin Physicians Service Insurance Corporation
L38303MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized DiseaseLCDCGS Administrators, LLC
L38339MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized DiseaseLCDNoridian Healthcare Solutions, LLC
L38341MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized DiseaseLCDNoridian Healthcare Solutions, LLC
L38292MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized DiseaseLCDPalmetto GBA
L38433MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized DiseaseLCDWisconsin Physicians Service Insurance Corporation
L38288MolDX: Repeat Germline TestingLCDCGS Administrators, LLC
L38351MolDX: Repeat Germline TestingLCDNoridian Healthcare Solutions, LLC
L38353MolDX: Repeat Germline TestingLCDNoridian Healthcare Solutions, LLC
L38274MolDX: Repeat Germline TestingLCDPalmetto GBA
L38429MolDX: Repeat Germline TestingLCDWisconsin Physicians Service Insurance Corporation
L34519Molecular Pathology ProceduresLCDFirst Coast Service Options, Inc.
L35000Molecular Pathology ProceduresLCDNational Government Services, Inc.
L34518Molecular Pathology Procedures for Human Leukocyte Antigen (HLA) TypingLCDFirst Coast Service Options, Inc.
DL39226
(Comments Ended 03/26/2022)
Multiplex Gastrointestinal Pathogen Panel (GPP) Tests for Acute Gastroenteritis (AGE)Proposed LCDNational Government Services, Inc.
A53848NCD - Pharmacogenomic Testing for Warfarin ResponseArticleFirst Coast Service Options, Inc.
DL33370
(Comments Ended 11/13/2021)
NebulizersProposed LCDCGS Administrators, LLC,
Noridian Healthcare Solutions, LLC
L38920Off-label Use of Rituximab and Rituximab BiosimilarsLCDCGS Administrators, LLC
A55653Parenteral Iron Administration Coverage in Non-Dialysis UsageArticleNoridian Healthcare Solutions, LLC
A55734Parenteral Iron Administration Coverage in Non-Dialysis UsageArticleNoridian Healthcare Solutions, LLC
DL39073
(Comments Ended 07/24/2021)
Pharmacogenomics TestingProposed LCDFirst Coast Service Options, Inc.
L39073Pharmacogenomics TestingLCDFirst Coast Service Options, Inc.
DL39063
(Comments Ended 07/24/2021)
Pharmacogenomics TestingProposed LCDNovitas Solutions, Inc.
L39063Pharmacogenomics TestingLCDNovitas Solutions, Inc.
L36675ProMark® Risk ScoreLCDCGS Administrators, LLC
L36704ProMark® Risk ScoreLCDNoridian Healthcare Solutions, LLC
L36706ProMark® Risk ScoreLCDNoridian Healthcare Solutions, LLC
L36665ProMark® Risk ScoreLCDPalmetto GBA
L37011ProMark® Risk ScoreLCDWisconsin Physicians Service Insurance Corporation
L35075Proton Beam TherapyLCDNational Government Services, Inc.
L34520Psychological and Neuropsychological TestsLCDFirst Coast Service Options, Inc.
A56247Response to Comments: Biomarker Testing for Neuroendocrine Tumors LCD L37851ArticleNational Government Services, Inc.
A54998Response to Comments: Controlled Substance Monitoring and Drugs of Abuse Testing Comment Period Ending 05/02/2014.ArticleNoridian Healthcare Solutions, LLC
A55031Response to Comments: Controlled Substance Monitoring and Drugs of Abuse Testing Comment Period Ending 05/02/2014.ArticleNoridian Healthcare Solutions, LLC
A55555Response to Comments: Diagnostic and Therapeutic ColonoscopyArticleNoridian Healthcare Solutions, LLC
A55558Response to Comments: Diagnostic and Therapeutic ColonoscopyArticleNoridian Healthcare Solutions, LLC
A58984Response to Comments: Genomic Sequence Analysis Panels in the Treatment of Solid Organ NeoplasmsArticleNational Government Services, Inc.
A54899Response to Comments: MolDX Biomarkers in Cardiovascular Risk AssessmentArticleCGS Administrators, LLC
A54988Response to Comments: MolDX Biomarkers in Cardiovascular Risk AssessmentArticleCGS Administrators, LLC
A56496Response to Comments: MolDX DecisionDx-MelanomaArticleCGS Administrators, LLC
A58198Response to Comments: MolDX Pharmacogenomics Testing (DL38435)ArticleWisconsin Physicians Service Insurance Corporation
A58072Response to Comments: MolDX Pigmented Lesion AssayArticleNoridian Healthcare Solutions, LLC
A58073Response to Comments: MolDX Pigmented Lesion AssayArticleNoridian Healthcare Solutions, LLC
A55540Response to Comments: MolDX-CDD: ConfirmMDx Epigenetic Molecular Assay (DL37005).ArticleWisconsin Physicians Service Insurance Corporation
A55398Response to Comments: MolDX-CDD: Decipher® Prostate Cancer Classifier Assay (L36791)ArticleWisconsin Physicians Service Insurance Corporation
A55396Response to Comments: MoLDX-CDD: Genomic Health™ Oncotype DX® Prostate Cancer Assay (L36789)ArticleWisconsin Physicians Service Insurance Corporation
A55452Response to Comments: MolDX: APC and MUTYH GeneArticleCGS Administrators, LLC
A55463Response to Comments: MolDX: APC and MUTYH Gene TestingArticleNoridian Healthcare Solutions, LLC
A55464Response to Comments: MolDX: APC and MUTYH Gene TestingArticleNoridian Healthcare Solutions, LLC
A55642Response to Comments: MolDX: APC and MUTYH Gene Testing (DL37224).ArticleWisconsin Physicians Service Insurance Corporation
A54978Response to Comments: MolDX: Biomarkers in Cardiovascular Risk AssessmentArticleNoridian Healthcare Solutions, LLC
A54979Response to Comments: MolDX: Biomarkers in Cardiovascular Risk AssessmentArticleNoridian Healthcare Solutions, LLC
A58452Response to Comments: MolDX: Blood Product Molecular Antigen TypingArticleCGS Administrators, LLC
A58505Response to Comments: MolDX: Blood Product Molecular Antigen TypingArticleNoridian Healthcare Solutions, LLC
A58506Response to Comments: MolDX: Blood Product Molecular Antigen TypingArticleNoridian Healthcare Solutions, LLC
A58306Response to Comments: MolDX: Blood Product Molecular Antigen TypingArticlePalmetto GBA
A58431Response to Comments: MolDX: Blood Product Molecular Antigen Typing (L38441)ArticleWisconsin Physicians Service Insurance Corporation
A56283Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression TestArticleCGS Administrators, LLC
A56356Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression TestArticleNoridian Healthcare Solutions, LLC
A56357Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression TestArticleNoridian Healthcare Solutions, LLC
A56272Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression TestArticlePalmetto GBA
A56338Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test (DL37913)ArticleWisconsin Physicians Service Insurance Corporation
A56230Response to Comments: MolDX: DecisionDx-MelanomaArticleNoridian Healthcare Solutions, LLC
A56231Response to Comments: MolDX: DecisionDx-MelanomaArticleNoridian Healthcare Solutions, LLC
A58514Response to Comments: MolDX: DecisionDX-MelanomaArticleWisconsin Physicians Service Insurance Corporation
A56635Response to Comments: MolDX: DecisionDX-Melanoma (L38018)ArticleWisconsin Physicians Service Insurance Corporation
A55876Response to Comments: MolDX: EndoPredict Breast Cancer Gene Expression TestArticleCGS Administrators, LLC
A55793Response to Comments: MolDX: EndoPredict® Breast Cancer Gene Expression TestArticleNoridian Healthcare Solutions, LLC
A55794Response to Comments: MolDX: EndoPredict® Breast Cancer Gene Expression TestArticleNoridian Healthcare Solutions, LLC
A56148Response to Comments: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)ArticleCGS Administrators, LLC
A56091Response to Comments: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)ArticleNoridian Healthcare Solutions, LLC
A56092Response to Comments: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)ArticleNoridian Healthcare Solutions, LLC
A56107Response to Comments: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)ArticleWisconsin Physicians Service Insurance Corporation
A54813Response to Comments: MolDX: HLA-DQB1 0602 Testing for NarcolepsyArticleCGS Administrators, LLC
A56354Response to Comments: MolDX: MDS FISHArticleCGS Administrators, LLC
A56446Response to Comments: MolDX: MDS FISHArticleNoridian Healthcare Solutions, LLC
A56447Response to Comments: MolDX: MDS FISHArticleNoridian Healthcare Solutions, LLC
A56329Response to Comments: MolDX: MDS FISHArticlePalmetto GBA
A56399Response to Comments: MolDX: MDS FISH (DL37772)ArticleWisconsin Physicians Service Insurance Corporation
A58480Response to Comments: MolDX: Melanoma Risk Stratification Molecular TestingArticleCGS Administrators, LLC
A58507Response to Comments: MolDX: Melanoma Risk Stratification Molecular TestingArticleNoridian Healthcare Solutions, LLC
A58508Response to Comments: MolDX: Melanoma Risk Stratification Molecular TestingArticleNoridian Healthcare Solutions, LLC
A58417Response to Comments: MolDX: Melanoma Risk Stratification Molecular TestingArticlePalmetto GBA
A58916Response to Comments: MolDX: Minimal Residual Disease Testing for CancerArticleCGS Administrators, LLC
A58953Response to Comments: MolDX: Minimal Residual Disease Testing for CancerArticleNoridian Healthcare Solutions, LLC
A58954Response to Comments: MolDX: Minimal Residual Disease Testing for CancerArticleNoridian Healthcare Solutions, LLC
A58915Response to Comments: MolDX: Minimal Residual Disease Testing for CancerArticlePalmetto GBA
A58930Response to Comments: MolDX: Minimal Residual Disease Testing for Cancer (DL38835)ArticleWisconsin Physicians Service Insurance Corporation
A54547Response to Comments: MolDX: Molecular Diagnostic Tests (MDT)ArticleNoridian Healthcare Solutions, LLC
A54552Response to Comments: MolDX: Molecular Diagnostic Tests (MDT)ArticleNoridian Healthcare Solutions, LLC
A54553Response to Comments: MolDX: Molecular Diagnostic Tests (MDT)ArticleNoridian Healthcare Solutions, LLC
A54554Response to Comments: MolDX: Molecular Diagnostic Tests (MDT)ArticleNoridian Healthcare Solutions, LLC
A59007Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification TestingArticleCGS Administrators, LLC
A59017Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification TestingArticleNoridian Healthcare Solutions, LLC
A59018Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification TestingArticleNoridian Healthcare Solutions, LLC
A59005Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification TestingArticlePalmetto GBA
A59020Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification TestingArticleWisconsin Physicians Service Insurance Corporation
A58687Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft RejectionArticleCGS Administrators, LLC
A58778Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft RejectionArticleNoridian Healthcare Solutions, LLC
A58780Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft RejectionArticleNoridian Healthcare Solutions, LLC
A58675Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft RejectionArticlePalmetto GBA
A58703Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft RejectionArticleWisconsin Physicians Service Insurance Corporation
A56161Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral PanelsArticleCGS Administrators, LLC
A56251Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral PanelsArticleNoridian Healthcare Solutions, LLC
A56255Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral PanelsArticleNoridian Healthcare Solutions, LLC
A56169Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels (DL37764)ArticleWisconsin Physicians Service Insurance Corporation
A56427Response to Comments: MolDX: myPath Melanoma AssayArticleCGS Administrators, LLC
A56387Response to Comments: MolDX: myPath Melanoma AssayArticleNoridian Healthcare Solutions, LLC
A56388Response to Comments: MolDX: myPath Melanoma AssayArticleNoridian Healthcare Solutions, LLC
A56379Response to Comments: MolDX: myPath Melanoma AssayArticlePalmetto GBA
A56509Response to Comments: MolDX: myPath Melanoma Assay (DL37923)ArticleWisconsin Physicians Service Insurance Corporation
A57877Response to Comments: MolDX: Next Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid MalignanciesArticleCGS Administrators, LLC
A57894Response to Comments: MolDX: Next Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid MalignanciesArticleNoridian Healthcare Solutions, LLC
A57909Response to Comments: MolDX: Next Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid MalignanciesArticleNoridian Healthcare Solutions, LLC
A57836Response to Comments: MolDX: Next Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid MalignanciesArticlePalmetto GBA
A57876Response to Comments: MolDX: Next-Generation Sequencing for Solid TumorsArticleCGS Administrators, LLC
A57904Response to Comments: MolDX: Next-Generation Sequencing for Solid TumorsArticleNoridian Healthcare Solutions, LLC
A57906Response to Comments: MolDX: Next-Generation Sequencing for Solid TumorsArticleNoridian Healthcare Solutions, LLC
A57830Response to Comments: MolDX: Next-Generation Sequencing for Solid TumorsArticlePalmetto GBA
A57879Response to Comments: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (DL38176)ArticleWisconsin Physicians Service Insurance Corporation
A58178Response to Comments: MolDX: Pharmacogenomics TestingArticleCGS Administrators, LLC
A58237Response to Comments: MolDX: Pharmacogenomics TestingArticleNoridian Healthcare Solutions, LLC
A58238Response to Comments: MolDX: Pharmacogenomics TestingArticleNoridian Healthcare Solutions, LLC
A58157Response to Comments: MolDX: Pharmacogenomics TestingArticlePalmetto GBA
A57916Response to Comments: MolDX: Pigmented Lesion AssayArticleCGS Administrators, LLC
A57869Response to Comments: MolDX: Pigmented Lesion AssayArticlePalmetto GBA
A57979Response to Comments: MolDX: Pigmented Lesion AssayArticleWisconsin Physicians Service Insurance Corporation
A57918Response to Comments: MolDX: Plasma-Based Genomic Profiling in Solid TumorsArticleCGS Administrators, LLC
A57866Response to Comments: MolDX: Plasma-Based Genomic Profiling in Solid TumorsArticlePalmetto GBA
A57935Response to Comments: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (L38168)ArticleWisconsin Physicians Service Insurance Corporation
A58735Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder CancerArticleCGS Administrators, LLC
A58748Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder CancerArticleNoridian Healthcare Solutions, LLC
A58749Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder CancerArticleNoridian Healthcare Solutions, LLC
A58729Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder CancerArticlePalmetto GBA
A58791Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer DL38684ArticleWisconsin Physicians Service Insurance Corporation
A55566Response to Comments: MolDX: Prolaris™ Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk DiseaseArticleCGS Administrators, LLC
A55778Response to Comments: MolDX: Prometheus IBD sgi Diagnostic PolicyArticleNoridian Healthcare Solutions, LLC
A55779Response to Comments: MolDX: Prometheus IBD sgi Diagnostic PolicyArticleNoridian Healthcare Solutions, LLC
A58368Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized DiseaseArticleCGS Administrators, LLC
A58509Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized DiseaseArticleNoridian Healthcare Solutions, LLC
A58511Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized DiseaseArticleNoridian Healthcare Solutions, LLC
A58344Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized DiseaseArticlePalmetto GBA
A58450Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease (DL38433)ArticleWisconsin Physicians Service Insurance Corporation
A58040Response to Comments: MolDX: Repeat Germline TestingArticleCGS Administrators, LLC
A58176Response to Comments: MolDX: Repeat Germline TestingArticleNoridian Healthcare Solutions, LLC
A58177Response to Comments: MolDX: Repeat Germline TestingArticleNoridian Healthcare Solutions, LLC
A58016Response to Comments: MolDX: Repeat Germline TestingArticlePalmetto GBA
A58118Response to Comments: MolDX: Repeat Germline Testing (L38429)ArticleWisconsin Physicians Service Insurance Corporation
A55564Response to Comments: MolDX: VitaRisk ™ Pharmacogenetic Test for Dry Age-related Macular Degeneration (AMD)ArticleCGS Administrators, LLC
A55334Response to Comments: Molecular Pathology ProceduresArticleNational Government Services, Inc.
A55982Response to Comments: Molecular Pathology ProceduresArticleNational Government Services, Inc.
A54588Response to Comments: MoPath: Special Histochemical Stains and Immunohistochemical StainsArticleCGS Administrators, LLC
A57861Response to Comments: Next-Generation Sequencing for Solid Tumor (DL38158)ArticleWisconsin Physicians Service Insurance Corporation
A56058Response to Comments: Nusinersen (Spinraza)ArticleNovitas Solutions, Inc.
A58922Response to Comments: Pharmacogenomics TestingArticleFirst Coast Service Options, Inc.
A58929Response to Comments: Pharmacogenomics TestingArticleNovitas Solutions, Inc.
A54586Response to Comments: Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II prothrombin, and MTHFR)ArticleCGS Administrators, LLC
A59001Response to Comments: Treatment of Varicose Veins of the Lower ExtremitiesArticlePalmetto GBA
A55475Response to Comments: Visual Electrophysiology TestingArticleNational Government Services, Inc.
A56401Response to Comments: Voretigene Neparvovec-rzyl (Luxturna™)ArticlePalmetto GBA
L35026RituximabLCDPalmetto GBA
DL38968
(Comments Ended 07/17/2021)
Thyroid Nodule Molecular TestingProposed LCDNational Government Services, Inc.
L38968Thyroid Nodule Molecular TestingLCDNational Government Services, Inc.
L38720Treatment of Chronic Venous Insufficiency of the Lower ExtremitiesLCDFirst Coast Service Options, Inc.
L34924Treatment of Chronic Venous Insufficiency of the Lower ExtremitiesLCDNovitas Solutions, Inc.
L36538Treatment of Males with Low TestosteroneLCDNoridian Healthcare Solutions, LLC
L36569Treatment of Males with Low TestosteroneLCDNoridian Healthcare Solutions, LLC
DL39086
(Comments Ended 11/06/2021)
Treatment of Males with Low TestosteroneProposed LCDPalmetto GBA
L39086
(Notice Ended 02/12/2022)
Treatment of Males with Low TestosteroneLCDPalmetto GBA
L35007Vestibular and Audiologic Function StudiesLCDNovitas Solutions, Inc.
L33767Viscosupplementation Therapy For KneeLCDFirst Coast Service Options, Inc.
L37535Vitamin D Assay TestingLCDNational Government Services, Inc.
L34051Vitamin D Assay TestingLCDNoridian Healthcare Solutions, LLC
L36692Vitamin D Assay TestingLCDNoridian Healthcare Solutions, LLC
L37863Voretigene Neparvovec-rzyl (Luxturna®)LCDPalmetto GBA
A52505Wheelchair Seating - Policy ArticleArticleCGS Administrators, LLC,
Noridian Healthcare Solutions, LLC
Active Medicare Coverage Determinations and Articles for Genetics as of May 12 2022